Alzheimer Disease
Conditions
Brief summary
Alzheimer's disease is the most common type of dementia, accounting for 50% of all cases. Advanced age is a significant risk factor for AD. Virtual Reality (VR) is an interactive video game technology that provides computer-generated environments that include physical activity and provide users with experiences similar to those in the real world. VR technology can be used for rehabilitation purposes in individuals with various orthopedic and neurological disorders due to its ability to enhance motor, cognitive learning and neural plasticity (1,2). The aim of our study was to examine the effect of the Virtual Reality Training Program on cognition in individuals with Alzheimer's disease living in the community.
Detailed description
The aim of our study was to examine the effect of the Virtual Reality Training Program on cognition in individuals with Alzheimer's disease living in the community. Prospective Randomized Controlled Single Blind Study After the patients and their relatives are informed in detail before the study, they will be asked whether they want to participate in the study and the individuals or relatives of the patients who approve of participating in the study will be asked to sign the informed consent form. Individuals who meet the inclusion criteria will be randomly divided into three groups by a single researcher: Virtual reality training program, cognitive exercise with traditional balance exercises, and traditional balance exercises only.
Interventions
DEVICEVirtual reality training
Virtual reality training
OTHERConventional exercise and cognitive exercise
Conventional exercise and cognitive exercise
OTHERcontrol
no intervention
Sponsors
Yeditepe University
Study design
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Subject)
Eligibility
Sex/Gender
ALL
Age
55 Years to 90 Years
Healthy volunteers
Yes
Inclusion criteria
* ≥ 55 years and older Diagnosed with AD according to DSM-IV diagnostic criteria by a neurologist, MOCA ≥ 16 Clinical Dementia Rating Scale \< 2
Exclusion criteria
* Various mobility restrictions, musculoskeletal disorders, (wheelchair use, etc.) Clinically significant aphasia (must be able to understand the therapist's commands) Significant visual or sensory impairment
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Montreal cognitive assessment scale | 12 weeks | MOCA is a short cognitive assessment method developed to detect particularly mild stages of cognitive impairment. |
| Berg Balance Scale | 12 weeks | BBS measures static and dynamic balance in elderly individuals |
| Time up and Go Test | 12 weeks | TUG test evaluates fall risk, mobility and physical performance in the elderly |
Countries
Turkey (Türkiye)
Contacts
Primary ContactEbru Akbuga Koc
Outcome results
None listed